Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

45.20p
   
  • Change Today:
      1.70p
  • 52 Week High: 135.00p
  • 52 Week Low: 10.25p
  • Currency: UK Pounds
  • Shares Issued: 106.84m
  • Volume: 1,180,027
  • Market Cap: £48.29m
  • RiskGrade: 594

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Sareum allowed European patent for primary kinase inhibitor asset

By Josh White

Date: Friday 15 Mar 2024

(Sharecast News) - Biotechnology company Sareum announced on Friday that the European Patent Office had issued a notice of allowance for a patent concerning SDC‐1801, its primary TYK2/JAK1 kinase inhibitor currently undergoing clinical trials in Australia.

Sareum reports positive progress in psoriasis programme

By Josh White

Date: Thursday 15 Feb 2024

(Sharecast News) - Sareum announced significant milestones in its phase 1a clinical trial for SDC-1801, its lead programme aimed at addressing autoimmune diseases such as psoriasis, on Thursday.

Sareum shares jump on cancer drug licensing deal

By Benjamin Chiou

Date: Tuesday 02 Jan 2024

(Sharecast News) - Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a commercialisation licence agreement with a US biopharma company.

Sareum secures Japan patent for kinase inhibitor... 03-Nov-2023 ShareCast
Sareum losses widen as clinical trials continue 09-Oct-2023 ShareCast
Director dealings: Blackbird, Sareum insiders pi... 06-Sep-2023 ShareCast
Sareum granted new patents in China, US 26-Jun-2023 ShareCast
Sareum gets approval for phase one psoriasis stu... 05-May-2023 ShareCast
Sareum looks at options as GSK division returns ... 06-Mar-2023 ShareCast
Sareum confident despite recent setbacks 16-Dec-2022 ShareCast
Sareum progresses Covid-19 and autoimmune treatm... 16-Mar-2022 ShareCast
Sareum expects FY losses to widen on higher R&D ... 19-Aug-2021 ShareCast
Sareum positive on SRA737 outlook after Sierra c... 06-Aug-2021 ShareCast
Sareum releases 'encouraging' results from Covid... 01-Jul-2021 ShareCast
Sareum's pre-clinical development of SDC-1801 de... 25-May-2021 ShareCast
Sareum gets approval for US patent application 07-Jan-2021 ShareCast
Sareum Holdings secures grant for Covid-19 treat... 03-Dec-2020 ShareCast
Sareum gets conditional approval for UKRI grant 27-Oct-2020 ShareCast
Sareum to get US patent on SDC-1802 programme 08-Oct-2020 ShareCast
Sareum Holdings upbeat ahead of cancer research ... 27-Sep-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 45.20p
Change Today 1.70p
% Change 3.91 %
52 Week High 135.00p
52 Week Low 10.25p
Volume 1,180,027
Shares Issued 106.84m
Market Cap £48.29m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.48% below the market average51.48% below the market average51.48% below the market average51.48% below the market average51.48% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
86.3% below the market average86.3% below the market average86.3% below the market average86.3% below the market average86.3% below the market average
51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sareum Holdings Dividends

No dividends found

Trades for 03-Jun-2024

Time Volume / Share Price
15:05 58,849 @ 45.88p
15:37 45,209 @ 47.02p
16:35 1,319 @ 45.20p
16:35 1,319 @ 45.20p
16:29 2,372 @ 46.55p

Sareum Holdings Key Personnel

CEO Timothy J Mitchell

Top of Page